Your browser doesn't support javascript.
loading
Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response.
Merrick, Victoria M; Mortier, Kajal; Williams, Linda J; Muhammed, Rafeeq; Auth, Marcus K H; Elawad, Mamoun; Fell, John M E; Beattie, R Mark; Loganathan, Sabarinathan; Torrente, Franco; Morris, Mary-Anne; Charlton, Charles; Croft, Nick M; Rodrigues, Astor; Furman, Mark; Vadamalayan, Babu; Jenkins, Huw; Zamvar, Veena; Mitton, Sally G; Chong, Sonny; Cosgrove, Mike; Akobeng, Anthony; Wilson, David C; Russell, Richard K.
Affiliation
  • Merrick VM; Child Life and Health, University of Edinburgh, Edinburgh.
  • Mortier K; UK IBD Audit, Royal College of Physicians, Regent's Park, London.
  • Williams LJ; Usher Institute of Population Health Sciences & Informatics, University of Edinburgh, Edinburgh.
  • Muhammed R; Department of PGHAN, Birmingham Children's Hospital, Birmingham.
  • Auth MKH; Department of PGHAN, Alder Hey Children's NHS Foundation Trust, Liverpool.
  • Elawad M; Department of PGHAN, Great Ormond Street Hospital, London.
  • Fell JME; Department of PGHAN, Chelsea and Westminster Hospital, London.
  • Beattie RM; Department of PGHAN, Southampton Children's Hospital, Southampton.
  • Loganathan S; Department of PGHAN, Royal Aberdeen Children's Hospital, Forresterhill, Aberdeen.
  • Torrente F; Department of PGHAN, Addenbrooke's Hospital, Cambridge.
  • Morris MA; Jenny Lind Children's Hospital, Norfolk and Norwich University Hospital, Norwich.
  • Charlton C; Department of PGHAN, Nottingham Children's Hospital, Nottingham.
  • Croft NM; Department of PGHAN, The Royal London Children's Hospital, Barts Health NHS Trust, London.
  • Rodrigues A; Department of PGHAN, Children's Hospital, John Radcliffe Hospital, Oxford.
  • Furman M; Department of PGHAN, Royal Free Hospital.
  • Vadamalayan B; Department of PGHAN, King's College Hospital, London.
  • Jenkins H; Department of PGHAN, Children's Hospital for Wales, Cardiff.
  • Zamvar V; Department of PGHAN, Clarendon Wing, Leeds General Infirmary, Leeds, West Yorkshire.
  • Mitton SG; Department of PGHAN, St George's Hospital, Tooting, London.
  • Chong S; Queen Mary's Hospital for Children, Carshalton.
  • Cosgrove M; Department of paediatrics, Singleton Hospital, Sketty, Swansea.
  • Akobeng A; Department of PGHAN, Royal Manchester Children's Hospital, Manchester.
  • Wilson DC; Department of PGHAN, Royal Hospital for Sick Children, Edinburgh.
  • Russell RK; Department of PGHAN, Royal Hospital for Children, Glasgow, UK.
J Pediatr Gastroenterol Nutr ; 66(2): 274-280, 2018 02.
Article in En | MEDLINE | ID: mdl-29356768
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Inflammatory Bowel Diseases / Immunosuppression Therapy / Tumor Necrosis Factor-alpha / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials / Observational_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: J Pediatr Gastroenterol Nutr Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Inflammatory Bowel Diseases / Immunosuppression Therapy / Tumor Necrosis Factor-alpha / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials / Observational_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: J Pediatr Gastroenterol Nutr Year: 2018 Document type: Article Country of publication: